Biohaven’s valuation has dropped from $3.9B to $1.42B, but no revenue and high cash burn still limit its appeal. Read why ...

Biohaven reported $462.5 million in 2021 product sales, a more than 600% increase over the prior year. Pfizer now aims to replicate that growth in Europe.

Law Offices of Howard G. Smith reminds investors of the upcoming September 12, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Biohaven Ltd.

THE LAWSUIT: A class action securities lawsuit was filed against Biohaven Ltd. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between March 24, ...

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...

Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now. Earlier on June 10, Bexorg Inc., which is a ...

Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd.

NEW HAVEN, Conn., Sept. 10, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biotechnology company focused on advancing innovative therapies for neurological and ...

Biohaven's neuroinnovation portfolio includes FDA-approved NURTEC ODT (rimegepant) for the acute and preventive treatment of migraine and a broad pipeline of late-stage product candidates across ...

Biohaven’s migraine drug research led to an FDA-approved product with strong commercial uptake, but its other neuroscience efforts have yet to achieve the same outcomes. Drug candidate ...

Biohaven may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on Biohaven's forward-looking statements.

Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (NYSE: ...